AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionPhysicians Financial Services, Inc.
Latest Disclosed Ownership12,075 shares
Latest Disclosed Value $ 2,626
Physicians Financial Services, Inc. reports 1.90% increase in ownership of 4AB / AbbVie Inc.

On April 15, 2026 - Physicians Financial Services, Inc. filed a 13F-HR form disclosing ownership of 12,075 shares of AbbVie Inc. (BG:4AB) valued at $2,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 11,850 shares of AbbVie Inc.. This represents a change in shares of 1.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F AbbVie COM 00287Y109 12,075 225 1.90 3 0.00 0.7190
2026-01-21 2025-12-31 13F AbbVie COM 00287Y109 11,850 -225 -1.86 3 0.00 0.7265
2025-10-21 2025-09-30 13F AbbVie COM 00287Y109 12,075 0 0.00 3 0.00 0.7633
2025-08-14 2025-06-30 13F AbbVie COM 00287Y109 12,075 -50 -0.41 2 0.00 0.6675
2025-05-07 2025-03-31 13F/A-1 AbbVie COM 00287Y109 12,125 -25 -0.21 3 0.00 0.8077
2025-05-07 2025-03-31 13F AbbVie COM 00287Y109 12,125 -25 3 0.8077
2025-02-03 2024-12-31 13F AbbVie COM 00287Y109 12,150 55 0.45 2 0.00 0.6555
2024-10-31 2024-09-30 13F AbbVie COM 00287Y109 12,095 -450 -3.59 2 0.00 0.7429
2024-08-14 2024-06-30 13F AbbVie COM 00287Y109 12,545 660 5.55 2 0.00 0.6999
2024-05-10 2024-03-31 13F AbbVie COM 00287Y109 11,885 -375 -3.06 2 100.00 0.7620
2024-01-26 2023-12-31 13F AbbVie COM 00287Y109 12,260 0 0.00 2 0.00 0.7201
2023-10-31 2023-09-30 13F AbbVie COM 00287Y109 12,260 0 0.00 2 0.00 0.7476
2023-07-26 2023-06-30 13F AbbVie COM 00287Y109 12,260 -35 -0.28 2 0.00 0.6486
2023-05-17 2023-03-31 13F AbbVie COM 00287Y109 12,295 0 0.00 2 0.00 0.8283
2023-02-09 2022-12-31 13F AbbVie COM 00287Y109 12,295 0 0.00 2 -99.94 0.8947
2022-10-19 2022-09-30 13F AbbVie COM 00287Y109 12,295 -700 -5.39 1,650 -17.09 0.7974
2022-08-17 2022-06-30 13F AbbVie COM 00287Y109 12,995 675 5.48 1,990 -0.35 0.8855
2022-04-22 2022-03-31 13F AbbVie COM 00287Y109 12,320 -90 -0.73 1,997 18.87 0.7624
2022-02-02 2021-12-31 13F AbbVie COM 00287Y109 12,410 -135 -1.08 1,680 24.17 0.6213
2021-10-27 2021-09-30 13F AbbVie COM 00287Y109 12,545 -208 -1.63 1,353 -5.78 0.5481
2021-07-27 2021-06-30 13F AbbVie COM 00287Y109 12,753 -660 -4.92 1,436 -1.10 0.5889
2021-05-21 2021-03-31 13F AbbVie COM 00287Y109 13,413 9,305 226.51 1,452 230.00 0.6222
2021-02-03 2020-12-31 13F AbbVie COM 00287Y109 4,108 475 13.07 440 38.36 0.2124
2020-11-10 2020-09-30 13F AbbVie COM 00287Y109 3,633 0 0.00 318 -10.92 0.1587
2020-07-28 2020-06-30 13F AbbVie COM 00287Y109 3,633 800 28.24 357 65.28 0.1973
2020-04-27 2020-03-31 13F AbbVie COM 00287Y109 2,833 0 0.00 216 -13.94 0.1485
2020-02-12 2019-12-31 13F AbbVie COM 00287Y109 2,833 0 0.00 251 16.74 0.1358
2019-11-14 2019-09-30 13F AbbVie COM 00287Y109 2,833 0 0.00 215 4.37 0.1230
2019-08-12 2019-06-30 13F AbbVie COM 00287Y109 2,833 100 3.66 206 -6.36 0.1212
2019-04-12 2019-03-31 13F AbbVie COM 00287Y109 2,733 0 0.00 220 -12.70 0.1367
2019-01-22 2018-12-31 13F AbbVie COM 00287Y109 2,733 2,733 252 0.1832
2018-04-17 2018-03-31 13F AbbVie COM 00287Y109 0 -2,735 -100.00 0 -100.00
2018-02-12 2017-12-31 13F AbbVie COM 00287Y109 2,735 0 0.00 265 9.05 0.2022
2017-11-01 2017-09-30 13F AbbVie COM 00287Y109 2,735 2,735 243 0.1987
2017-04-26 2017-03-31 13F AbbVie COM 00287Y109 0 -5,850 -100.00 0 -100.00
2017-01-17 2016-12-31 13F AbbVie COM 00287Y109 5,850 225 4.00 380 7.34 0.3119
2016-11-01 2016-09-30 13F AbbVie COM 00287Y109 5,625 -206 -3.53 354 -1.94 0.2952
2016-07-14 2016-06-30 13F AbbVie COM 00287Y109 5,831 -298 -4.86 361 3.14 0.3159
2016-04-26 2016-03-31 13F AbbVie COM 00287Y109 6,129 2 0.03 350 -3.58 0.3167
2016-02-09 2015-12-31 13F AbbVie COM 00287Y109 6,127 6,127 363 0.3353
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.